sermorelin with retatrutide Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial The Peptide Craze - Ground
Description
Tirzepatide is a dual-agonist for GLP-1 and GIP
Alternative options include taking levothyroxine at bedtime (at least 3-4 hours after the last meal) with clinician guidance
liquid options may be better tolerated post-workout
Half-life and T max were not significantly altered after administration of food
While prescription GLP-1 medications can be effective, they are not without risks
Distribute protein evenly across three meals rather than frontloading it, since reduced appetite from GLP-1 therapy makes large portions difficult
